| Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein KM Jaruszewski, S Ramakrishnan, JF Poduslo, KK Kandimalla Nanomedicine: Nanotechnology, Biology and Medicine 8 (2), 250-260, 2012 | 77 | 2012 |
| Multimodal Nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain KM Jaruszewski, GL Curran, SK Swaminathan, JT Rosenberg, SC Grant, ... Biomaterials 35 (6), 1967-1976, 2014 | 73 | 2014 |
| Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits EK Agyare, KM Jaruszewski, GL Curran, JT Rosenberg, SC Grant, ... Journal of controlled release 185, 121-129, 2014 | 69 | 2014 |
| Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain KM Ahlschwede, GL Curran, JT Rosenberg, SC Grant, G Sarkar, ... Nanomedicine: Nanotechnology, Biology and Medicine 16, 258-266, 2019 | 57 | 2019 |
| Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain SK Swaminathan, KM Ahlschwede, V Sarma, GL Curran, RS Omtri, ... Journal of Cerebral Blood Flow & Metabolism 38 (5), 904-918, 2018 | 54 | 2018 |
| Nanotechnology-based therapies for the prevention and treatment of Streptococcus mutans-derived dental caries F Amissah, T Andey, KM Ahlschwede Journal of oral biosciences 63 (4), 327-336, 2021 | 21 | 2021 |
| High-density lipoprotein mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid-β distribution between brain and plasma SK Swaminathan, AL Zhou, KM Ahlschwede, GL Curran, VJ Lowe, L Li, ... Journal of Pharmacology and Experimental Therapeutics 375 (2), 308-316, 2020 | 14 | 2020 |
| Distinct uptake kinetics of Alzheimer disease amyloid-β 40 and 42 at the blood-brain barrier endothelium N Sharda, KM Ahlschwede, GL Curran, VJ Lowe, KK Kandimalla Journal of Pharmacology and Experimental Therapeutics 376 (3), 482-490, 2021 | 12 | 2021 |
| Age-dependent changes in the plasma and brain pharmacokinetics of amyloid-β peptides and insulin AL Zhou, N Sharda, VV Sarma, KM Ahlschwede, GL Curran, X Tang, ... Journal of Alzheimer's Disease 85 (3), 1031-1044, 2022 | 8 | 2022 |
| P1‐197: AMYLOID BETA EFFECTS ON INSULIN PERMEABILITY FROM PLASMA TO BRAIN MEASURED BY I‐125 INSULIN SPECT IN APP/PS1 MICE SK Swaminathan, HK Min, VV Sarma, KM Ahlschwede, TJ Bruinsma, ... Alzheimer's & Dementia 14 (7S_Part_6), P354-P354, 2018 | 3 | 2018 |
| Role of nanotechnology in the diagnosis and treatment of Alzheimer’s KM Jaruszewski, RS Omtri, KK Kandimalla Curr Adv Med Appl Nanotechnol 107, 2012 | 3 | 2012 |
| Evaluating the effect of cationic peptide K16ApoE against Staphylococcus epidermidis biofilms KM Ahlschwede, F Amissah, R Deshmukh Journal of Pharmaceutical Investigation 52 (1), 139-149, 2022 | 2 | 2022 |
| Formulation, characterization, and the diuretic effects of a new intravenous metolazone emulsion KM Ahlschwede, E Ofori, T Andey, A Osei, JS Somberg Drug Research 72 (06), 299-305, 2022 | 1 | 2022 |
| HDL mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid beta distribution between brain and plasma SK Swaminathan, AL Zhou, KM Ahlschwede, GL Curran, VJ Lowe, L Li, ... Journal of Pharmacology and Experimental Therapeutics, 2020 | 1 | 2020 |
| Development of a novel approach to enhance the solubility of ftibamzone formulation O Udofot, K Jaruszewski, S Spencer, E Agyare Integrative molecular medicine 1 (3), 61, 2014 | 1 | 2014 |
| Analytical methodologies to isolate and quantify free and liposomal bound doxorubicin from biological samples using LC-HRMS and LC-QQQ-MS P Sisco, K Ahlschwede, J Leakey, S Linder ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |
| Cryo Transmission Electron Microscopy of Three Research-Grade Liposomal Formulations of Doxorubicin W Monroe, A Paredes, P Sisco, K Ahlschwede, S Linder Microscopy and Microanalysis 21 (S3), 927-928, 2015 | | 2015 |
| Engineering of a MRI Theranostic Agent for Detection and Treatment of Cerebrovascular Amyloid JT Rosenberg, KMJ Ahlschwede, EK Agyare, GL Curran, SC Grant, ... | | |
| Multimodal Nanoprobes to Target Cerebrovascular Amyloid in the Alzheimer’s Brain KM Jaruszewski, GL Curran, SK Swaminathan, JT Rosenberg, SC Grant, ... | | |
| engineering theranostic Nanovehicles to target cerebrovascular amyloid deposits E Agyare, KM Jaruszewski, GL Curran, JT Rosenberg, SC Grant, VJ Lowe, ... in every issue, 51, 0 | | |
